Biogen, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US09062X1037
USD
181.98
1.8 (1.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
9,266.60
9,417.00
9,433.40
10,402.40
12,356.00
12,714.00
12,052.70
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
9,266.60
9,417.00
9,433.40
10,402.40
12,356.00
12,714.00
12,052.70
Raw Material Cost
2,983.60
3,028.20
2,797.00
2,597.00
2,262.20
2,420.00
2,197.50
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
250.30
246.90
246.60
253.60
225.80
187.40
200.60
Selling and Distribution Expenses
2,403.70
2,549.70
2,403.60
2,674.30
2,504.50
2,374.70
2,095.40
Other Expenses
150.48
196.09
171.21
201.23
356.32
190.26
239.66
Total Expenditure (Excl Depreciation)
7,142.40
7,785.70
7,159.30
7,537.20
8,555.70
6,884.70
6,890.10
Operating Profit (PBDIT) excl Other Income
2124.2
1631.3
2274.1
2865.2
3800.2999999999997
5829.299999999999
5162.6
Other Income
101.30
129.80
2,570.80
-218.10
1,648.30
1,627.80
1,414.00
Operating Profit (PBDIT)
2,898.70
2,255.90
5,363.60
3,134.40
5,905.60
7,921.70
7,227.20
Interest
250.30
246.90
246.60
253.60
225.80
187.40
200.60
Exceptional Items
-69.20
-217.40
-1,006.50
-648.30
-175.30
-143.80
-476.40
Gross Profit (PBDT)
6,283.00
6,388.80
6,636.40
7,805.40
10,093.80
10,294.00
9,855.20
Depreciation
673.20
494.80
518.70
487.30
457.00
464.60
650.60
Profit Before Tax
1,906.00
1,296.80
3,591.80
1,745.20
5,047.50
7,125.90
5,899.60
Tax
273.80
135.30
632.80
52.50
992.30
1,158.00
1,425.60
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,632.20
1,161.10
3,046.90
1,556.10
4,000.60
5,888.50
4,430.70
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,632.20
1,161.10
3,046.90
1,556.10
4,000.60
5,888.50
4,430.70
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.40
-85.30
171.50
59.90
0.00
43.30
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,632.20
1,161.50
2,961.60
1,727.60
4,060.50
5,888.50
4,474.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
16,716.00
14,799.40
13,397.90
10,896.20
10,700.30
13,343.20
13,039.60
Earnings per share (EPS)
11.19
7.97
20.87
10.4
24.8
31.42
21.58
Diluted Earnings per share
11.19
7.97
20.87
10.4
24.8
31.42
21.58
Operating Profit Margin (Excl OI)
22.92%
17.32%
24.11%
27.54%
30.76%
45.85%
42.83%
Gross Profit Margin
27.83%
19.03%
43.57%
21.46%
44.55%
59.7%
54.35%
PAT Margin
17.61%
12.33%
32.3%
14.96%
32.38%
46.32%
36.76%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -1.60% vs -0.17% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 40.53% vs -60.78% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 31.57% vs -23.87% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 1.38% vs 0.12% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Biogen, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
9,266.60
3,236.00
6,030.60
186.36%
Other Operating Income
0.00
0.00
0.00
Total Operating income
9,266.60
3,236.00
6,030.60
186.36%
Raw Material Cost
2,983.60
1,653.00
1,330.60
80.50%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
250.30
24.00
226.30
942.92%
Selling and Distribution Expenses
2,403.70
1,174.00
1,229.70
104.74%
Other Expenses
150.48
433.00
-282.52
-65.25%
Total Expenditure (Excl Depreciation)
7,142.40
7,181.00
-38.60
-0.54%
Operating Profit (PBDIT) excl Other Income
2,124.20
-3,945.00
6,069.20
153.85%
Other Income
101.30
362.00
-260.70
-72.02%
Operating Profit (PBDIT)
2,898.70
-3,394.00
6,292.70
185.41%
Interest
250.30
24.00
226.30
942.92%
Exceptional Items
-69.20
0.00
-69.20
Gross Profit (PBDT)
6,283.00
1,583.00
4,700.00
296.90%
Depreciation
673.20
189.00
484.20
256.19%
Profit Before Tax
1,906.00
-3,607.00
5,513.00
152.84%
Tax
273.80
-46.00
319.80
695.22%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,632.20
-3,561.00
5,193.20
145.84%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,632.20
-3,561.00
5,193.20
145.84%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,632.20
-3,561.00
5,193.20
145.84%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
16,716.00
10,901.00
5,815.00
53.34%
Earnings per share (EPS)
11.19
-9.27
20.46
220.71%
Diluted Earnings per share
11.19
-9.27
20.46
220.71%
Operating Profit Margin (Excl OI)
22.92%
-121.91%
0.00
144.83%
Gross Profit Margin
27.83%
-105.62%
0.00
133.45%
PAT Margin
17.61%
-110.04%
0.00
127.65%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 926.66 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -1.60% vs -0.17% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 163.22 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 40.53% vs -60.78% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 279.74 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 31.57% vs -23.87% in Dec 2023

Annual - Interest
Interest 25.03 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 1.38% vs 0.12% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.92%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023